Pune, India -- (SBWire) -- 10/19/2016 --Batten Disease – Pipeline Review, H2 2016, provides an overview of the Batten Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Batten Disease , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Browse more detail information about Batten Disease Market Report at: http://www.absolutereports.com/batten-disease-pipeline-review-h2-2016-10351043
The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects.
Key players in Batten Disease – Pipeline Review, H2 2016:
Abeona Therapeutics, Inc.
BioMarin Pharmaceutical Inc.
CereSpir Incorporated
Evotec AG
Ionis Pharmaceuticals, Inc.
Mitochon Pharmaceuticals, Inc.
RegenxBio Inc.
Retrotope, Inc
Spark Therapeutics, Inc.
Get a PDF Sample of Batten Disease Market Research Report at: http://www.absolutereports.com/enquiry/request-sample/10351043
Drug Profiles of Included in Batten Disease Therapeutics Development Market Report
ABO-201
Antisense Oligonucleotides to Activate CLN3 for Batten Disease
cerliponase alfa
DUOC-01
Gene Therapy to Activate CLN1 and CLN2 for Batten Disease
Gene Therapy to Activate Palmitoyl Protein Thioesterase 1 for Batten Disease
And other drug profiles
Have any query? ask our expert @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10351043
List of Figures of Batten Disease Therapeutics Market Included:
- Number of Products under Development for Batten Disease , H2 2016
- Number of Products under Development for Batten Disease -Comparative Analysis, H2 2016
- Number of Products under Development by Companies, H2 2016
- Number of Products under Investigation by Universities/Institutes, H2 2016
- Comparative Analysis by Clinical Stage Development, H2 2016
- Comparative Analysis by Early Stage Products, H2 2016
- Assessment by Monotherapy Products, H2 2016
- Number of Products by Top 10 Targets, H2 2016
- Number of Products by Stage and Top 10 Targets, H2 2016
- Number of Products by Top 10 Mechanism of Actions, H2 2016
- Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
- Number of Products by Top 10 Routes of Administration, H2 2016
- Number of Products by Stage and Top 10 Routes of Administration, H2 2016
- Number of Products by Top 10 Molecule Types, H2 2016
- Number of Products by Stage and Top 10 Molecule Types, H2 2016
Get Discount on Batten Disease Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/10351043
Scope of Batten Disease Pipeline Review Report-
– The report provides a snapshot of the global therapeutic landscape of Batten Disease
– The report reviews pipeline therapeutics for Batten Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
About Absolute Report
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Contact
Mr. Ameya Pingaley
Absolute Reports
408-520-9750
Email – sales@absolutereports.com
www.absolutereports.com
Batten Disease in Depth Therapeutic Landscape Pipeline Review H2 2016
Batten Disease Pipeline Review, H2 2016 descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.